Total Payments
$5,627
2024 Payments
$425.06
Companies
35
Transactions
369
Medicare Patients
7,166
Medicare Billing
$354,449
Payment Breakdown by Category
Food & Beverage$5,606 (99.6%)
Education$20.67 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,606 | 365 | 99.6% |
| Education | $20.67 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $932.97 | 62 | $0 (2024) |
| ABBVIE INC. | $793.99 | 58 | $0 (2024) |
| PFIZER INC. | $773.81 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $465.79 | 28 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $340.97 | 11 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $328.49 | 23 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $310.09 | 17 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $286.23 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $161.49 | 5 | $0 (2022) |
| Amgen Inc. | $151.43 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.06 | 26 | Almatica Pharma LLC ($81.84) |
| 2023 | $893.90 | 55 | AbbVie Inc. ($275.10) |
| 2022 | $847.84 | 58 | ABBVIE INC. ($293.21) |
| 2021 | $900.14 | 67 | PFIZER INC. ($176.22) |
| 2020 | $149.06 | 9 | PFIZER INC. ($56.29) |
| 2019 | $188.20 | 12 | Novo Nordisk Inc ($148.92) |
| 2018 | $766.14 | 47 | Novo Nordisk Inc ($175.98) |
| 2017 | $1,457 | 95 | Janssen Pharmaceuticals, Inc ($298.86) |
All Payment Transactions
369 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $16.43 | General |
| Category: Heart Failure and Hypertension | ||||||
| 08/27/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: ANTI-ANXIETY | ||||||
| 05/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 04/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Inflammation | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Cardiology | ||||||
| 03/14/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: ANTI-ANXIETY | ||||||
| 03/13/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: ANTI-ANXIETY | ||||||
| 02/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: ANTI-ANXIETY | ||||||
| 01/17/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 944 | 1,430 | $181,853 | $80,427 |
| 2022 | 28 | 1,853 | 2,392 | $186,224 | $91,791 |
| 2021 | 28 | 2,373 | 3,564 | $210,412 | $107,279 |
| 2020 | 28 | 1,996 | 2,847 | $169,372 | $74,952 |
Total Patients
7,166
Total Services
10,233
Medicare Billing
$354,449
Procedure Codes
104
All Medicare Procedures & Services
104 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90662 | Influenza vaccine split virus, preservative free | Facility | 2022 | 40 | 41 | $2,772 | $2,656 | 95.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 16 | 17 | $3,590 | $2,547 | 70.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 48 | 50 | $3,325 | $2,185 | 65.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 35 | 38 | $4,356 | $1,947 | 44.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 39 | $4,400 | $1,890 | 43.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 135 | 143 | $2,880 | $1,501 | 52.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 111 | 112 | $2,800 | $1,492 | 53.3% |
| G0008 | Administration of influenza virus vaccine | Facility | 2022 | 43 | 43 | $1,591 | $1,130 | 71.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 38 | $2,344 | $1,128 | 48.1% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 93 | 130 | $1,690 | $836.72 | 49.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 16 | 18 | $1,998 | $769.15 | 38.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 57 | 61 | $1,159 | $589.31 | 50.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 30 | 44 | $1,496 | $561.00 | 37.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 36 | 60 | $960.00 | $505.36 | 52.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 114 | 160 | $800.00 | $477.42 | 59.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 18 | $1,854 | $460.00 | 24.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 36 | 40 | $968.00 | $331.98 | 34.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 13 | 63 | $694.00 | $274.66 | 39.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2022 | 60 | 84 | $520.00 | $264.75 | 50.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 14 | 15 | $490.00 | $235.68 | 48.1% |
| 71045 | X-ray of chest, 1 view | Office | 2022 | 22 | 24 | $938.00 | $177.18 | 18.9% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2022 | 11 | 13 | $581.00 | $147.70 | 25.4% |
| 87140 | Identification of organisms by immunologic analysis, immunofluorescent method | Office | 2022 | 24 | 25 | $275.00 | $138.53 | 50.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 360 | 737 | $76,736 | $40,825 | 53.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 205 | 268 | $43,393 | $19,685 | 45.4% |
About Dr. Mark Bradshaw, M.D
Dr. Mark Bradshaw, M.D is a Family Medicine healthcare provider based in Wynne, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346355518.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Bradshaw, M.D has received a total of $5,627 in payments from pharmaceutical and medical device companies, with $425.06 received in 2024. These payments were reported across 369 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,606).
As a Medicare-enrolled provider, Bradshaw has provided services to 7,166 Medicare beneficiaries, totaling 10,233 services with total Medicare billing of $354,449. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Wynne, AR
- Active Since 08/20/2006
- Last Updated 03/29/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346355518
Products in Payments
- ELIQUIS (Drug) $519.94
- UBRELVY (Drug) $479.27
- Ozempic (Drug) $459.95
- TRELEGY ELLIPTA (Drug) $327.87
- JARDIANCE (Drug) $287.69
- QULIPTA (Drug) $257.08
- FARXIGA (Drug) $210.70
- XARELTO (Drug) $189.93
- Tresiba (Drug) $169.71
- ENTRESTO (Drug) $161.49
- GEMTESA (Drug) $158.89
- CHANTIX (Drug) $158.48
- Victoza (Drug) $142.01
- INVOKANA (Drug) $138.56
- AREXVY (Drug) $123.74
- LOREEV XR (Drug) $121.83
- Ranexa (Drug) $100.00
- Utibron (Drug) $93.82
- LYRICA (Drug) $88.16
- TOUJEO (Drug) $85.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Wynne
Dr. Willard Burks, M.d, M.D
Family Medicine — Payments: $5,354
Family Medicine $5,354
Dr. James Cathey, M.d, M.D
Family Medicine — Payments: $4,594
Family Medicine $4,594
Dr. James Beaton, M.d, M.D
Family Medicine — Payments: $3,374
Family Medicine $3,374
Sean Koch, Md, MD
Family Medicine — Payments: $3,138
Family Medicine $3,138
Jeremiah Nugent, M.d, M.D
Family Medicine — Payments: $2,336
Family Medicine $2,336
Mrs. Lesli Anderson, Aprn, APRN
Family Medicine — Payments: $390.90
Family Medicine $390.90